Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
96 studies found for:    Open Studies | "Heparin"
Show Display Options
Rank Status Study
21 Unknown  Efficacy and Safety of Sodium Heparin in Patients Submitted to Heart Surgery Using Bypass
Condition: Cardiac Surgery
Interventions: Drug: heparin sodium - Bergamo;   Drug: heparin sodium - APP
22 Recruiting High (100IU/Kg) Versus Standard (50IU/Kg) Heparin Dose for Prevention of Forearm Artery Occlusion
Condition: Coronary Angiography
Interventions: Drug: High dose of Unfractionated Heparin;   Drug: Standard dose of Unfractionated heparin
23 Recruiting Balloon Aortic Valvuloplasty Performed Without Heparin to Decrease Vascular and Bleeding Complications of the Procedure
Condition: Aortic Stenosis, Non-rheumatic
Interventions: Drug: Heparin;   Drug: NaCl
24 Unknown  Low-Molecular-Weight Heparin (LMWH) for Deep Venous Thrombosis (DVT) Prophylaxis
Condition: Deep Venous Thrombosis
Intervention: Drug: Low-Molecular-Weight Heparin
25 Recruiting Effect of Intravenous Continuous Infusion Heparin on Rates of Venous Thromboembolism in High-Risk, Critically Ill Patients
Condition: Venous Thromboembolism
Interventions: Drug: intravenous continuous infusion of heparin (IV UFH);   Drug: Subcutaneous Heparin
26 Recruiting A Comparison of Dilute Versus Concentrated Heparin for CRRT Anticoagulation
Conditions: Acute Kidney Injury;   Acute Renal Failure;   Heart Failure
Interventions: Drug: Dilute unfractionated heparin;   Drug: Standard concentration unfractionated heparin
27 Recruiting Efficacy and Safety of Heparin-coated Surface-treated Polyacrylonitrile Membrane Hemofilter in Critical Ill CRRT Patients
Conditions: Critical Ill Patients;   Patients Needing Continuous Renal Replacement Therapy
Interventions: Device: AN69ST hemofilter;   Device: AN69 hemofilter
28 Recruiting Thoracic Surgery Extended Low-Molecular Weight Heparin VTE Prophylaxis--Pilot Trial
Conditions: Venous Thromboembolism;   Lung Neoplasms;   Pulmonary Embolism
Interventions: Drug: LMWH: Dalteparin;   Other: Placebo
29 Not yet recruiting Efficacy and Safety of Unfractionated Heparin on Severe Sepsis With Suspected Disseminated Intravascular Coagulation
Conditions: Sepsis;   Disseminated Intravascular Coagulation
Interventions: Drug: Heparin Sodium;   Drug: Saline
30 Recruiting Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy
Conditions: Deep Venous Thrombosis;   Pulmonary Embolism
Interventions: Drug: Low dose nadroparin;   Drug: Intermediate dose nadroparin;   Drug: Low dose enoxaparin;   Drug: Intermediate dose enoxaparin;   Drug: Low dose dalteparin;   Drug: Intermediate dose dalteparin;   Drug: Fixed low dose tinzaparin;   Drug: Intermediate dose tinzaparin
31 Unknown  Study of Clinical Non-inferiority of Actparin® (Laboratorio Bergamo) Compared to Heparin Sodium (APP Pharmaceuticals), in Patients With Chronic Renal Failure
Condition: Chronic Renal Failure
Intervention: Biological: heparin sodium
32 Recruiting Low Molecular Weight Heparin to Improve Pregnancy Outcome in Patients With Recurrent Implantation Failure
Condition: Sterility
Intervention: Drug: Bemiparin sodium
33 Unknown  Residual Vein Thrombosis and the Optimal Duration of Low Molecular Weight Heparin in Cancer Patients With Deep Vein Thrombosis
Conditions: Deep Vein Thrombosis;   Cancer
Intervention: Drug: low molecular weight heparin
34 Recruiting Thromboprophylaxis After Surgery for Gynecologic Malignancy in China
Conditions: Gynecologic Neoplasms;   Venous Thromboembolism;   Low Molecular Weight Heparin;   Argatroban
Interventions: Drug: s-LMWH;   Drug: LMWH;   Drug: Argatroban
35 Not yet recruiting Therapeutic Anticoagulation Strategy for Acute Chest Syndrome
Conditions: Anemia;   Sickle Cell;   Acute Chest Syndrome;   Low-Molecular-Weight Heparin
Interventions: Drug: Prophylactic anticoagulation ( INNOHEP®);   Drug: Curative anticoagulation ( INNOHEP®)
36 Recruiting Heparin Based on Ideal Body Weight for Cardiopulmonary Bypass in Obese Patients
Conditions: Cardiac Surgery;   Cardiopulmonary Bypass;   Obese Patients (BMI ≥ 30 kg/m²)
Interventions: Drug: Heparin, IV route, based on patients body weights (UI/kg);   Procedure: Cardiopulmonary bypass;   Drug: Protamin administration
37 Not yet recruiting Low-molecular-weight Heparin in Constituted Vascular Intrauterine Growth Restriction
Condition: Fetal Growth Retardation
Interventions: Drug: Enoxaparin;   Other: Usual care
38 Unknown  Impact of Heparin on the Need for Mechanical Ventilation in Neonates
Conditions: Respiration, Artificial;   Hemorrhage
Intervention: Drug: heparin
39 Unknown  Citrate Versus Heparin for the Lock of Non-tunneled Hemodialysis Catheters in Patients Hospitalised in ICU
Condition: Patients With Acute Renal Insufficiency
Interventions: Drug: Citrate 4%;   Drug: unfractionated heparin
40 Unknown  Citrate Versus Heparin Anticoagulation: Effect on Molecules Clearances
Condition: Septic Shock
Interventions: Drug: Anticoagulation to prevent clotting of the extracorporeal circuit. (regional citrate anticoagulation);   Drug: Anticoagulation to prevent clotting of the extracorporeal circuit (Unfractionated heparin)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years